{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:52:05Z","timestamp":1781661125369,"version":"3.54.5"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:00:00Z","timestamp":1559174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009066","name":"Instituto Carlos Slim de la Salud","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Global Health Innovation Technology Fund","award":["G-2014-002"],"award-info":[{"award-number":["G-2014-002"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007413","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:25:11Z","timestamp":1559237111000},"page":"e0007413","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1866-0731","authenticated-orcid":true,"given":"Meagan A.","family":"Barry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leroy","family":"Versteeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1420-4015","authenticated-orcid":true,"given":"Jeroen","family":"Pollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Gusovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8770-1042","authenticated-orcid":true,"given":"Peter J.","family":"Hotez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,5,30]]},"reference":[{"issue":"6","key":"ref1","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"issue":"9723","key":"ref2","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"A Rassi Jr","year":"2010","journal-title":"Lancet"},{"issue":"10100","key":"ref3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"GBD Disease","year":"2017","journal-title":"Lancet"},{"key":"ref4","article-title":"Global economic burden of Chagas disease: a computational simulation model","author":"BY Lee","year":"2013","journal-title":"The Lancet infectious diseases"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/clc.22421","article-title":"The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease","volume":"38","author":"LH Malik","year":"2015","journal-title":"Clinical cardiology"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S1473-3099(15)00243-1","article-title":"Old and new challenges in Chagas disease","volume":"15","author":"JA Perez-Molina","year":"2015","journal-title":"The Lancet infectious diseases"},{"issue":"Suppl 1","key":"ref7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1590\/S0074-02762009000900021","article-title":"Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification","volume":"104","author":"A Rassi Jr","year":"2009","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"5","key":"ref8","first-page":"460","article-title":"Cardiac Magnetic Resonance-Verified Myocardial Fibrosis in Chagas Disease: Clinical Correlates and Risk Stratification","volume":"107","author":"M Uellendahl","year":"2016","journal-title":"Arquivos brasileiros de cardiologia"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ejhf.220","article-title":"Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity","volume":"17","author":"EC Sabino","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0188-4409(00)00261-7","article-title":"Persistence of Trypanosoma cruzi in chronic chagasic cardiopathy patients","volume":"32","author":"V Monteon-Padilla","year":"2001","journal-title":"Arch Med Res"},{"issue":"21","key":"ref11","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.jacc.2018.08.2195","article-title":"Long-Term Prognostic Value of Myocardial Fibrosis in Patients With Chagas Cardiomyopathy","volume":"72","author":"T Senra","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2004.05.025","article-title":"Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas\u2019 heart disease","volume":"102","author":"HF Freitas","year":"2005","journal-title":"International journal of cardiology"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa053241","article-title":"Development and validation of a risk score for predicting death in Chagas\u2019 heart disease","volume":"355","author":"A Rassi Jr.","year":"2006","journal-title":"The New England journal of medicine"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/clc.4960231205","article-title":"Chagas\u2019 heart disease","volume":"23","author":"A Rassi Jr.","year":"2000","journal-title":"Clinical cardiology"},{"issue":"14","key":"ref15","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized Trial of Benznidazole for Chronic Chagas\u2019 Cardiomyopathy","volume":"373","author":"CA Morillo","year":"2015","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11908-012-0259-3","article-title":"Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment","volume":"14","author":"JA Perez-Molina","year":"2012","journal-title":"Current infectious disease reports"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/381682","article-title":"Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease","volume":"189","author":"SA Laucella","year":"2004","journal-title":"The Journal of infectious diseases"},{"issue":"5681","key":"ref18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1126\/science.1100600","article-title":"Therapeutic vaccines for chronic infections","volume":"305","author":"B Autran","year":"2004","journal-title":"Science"},{"issue":"9","key":"ref19","article-title":"Modeling the economic value of a Chagas\u2019 disease therapeutic vaccine","volume":"8","author":"BY Lee","year":"2012","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"31","key":"ref20","doi-asserted-by":"crossref","first-page":"18627","DOI":"10.1016\/S0021-9258(18)51512-X","article-title":"A novel flagellar Ca2+-binding protein in trypanosomes","volume":"264","author":"DM Engman","year":"1989","journal-title":"The Journal of biological chemistry"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1128\/JCM.33.8.2082-2085.1995","article-title":"Utility of recombinant flagellar calcium-binding protein for serodiagnosis of Trypanosoma cruzi infection","volume":"33","author":"LM Godsel","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0035-9203(95)90052-7","article-title":"Use of a recombinant Trypanosoma cruzi protein antigen to monitor cure of Chagas disease","volume":"89","author":"AG Guevara","year":"1995","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/IAI.72.1.46-53.2004","article-title":"Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice","volume":"72","author":"E Dumonteil","year":"2004","journal-title":"Infect Immun"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1574-695X.2007.00251.x","article-title":"Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice","volume":"50","author":"G Sanchez-Burgos","year":"2007","journal-title":"FEMS immunology and medical microbiology"},{"issue":"46","key":"ref25","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1016\/j.vaccine.2010.08.104","article-title":"Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells","volume":"28","author":"AY Limon-Flores","year":"2010","journal-title":"Vaccine"},{"issue":"36","key":"ref26","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1016\/j.vaccine.2015.07.017","article-title":"Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice","volume":"33","author":"V Martinez-Campos","year":"2015","journal-title":"Vaccine"},{"key":"ref27","article-title":"A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB\/c mouse model of Chagas disease","author":"MA Barry","year":"2016","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1586\/14760584.6.5.773","article-title":"E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant","volume":"6","author":"ST Ishizaka","year":"2007","journal-title":"Expert review of vaccines"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4161\/hv.19229","article-title":"MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine","volume":"8","author":"M Singh","year":"2012","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1128\/CVI.00153-07","article-title":"Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome","volume":"14","author":"GL Morefield","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/erv.12.85","article-title":"Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects","volume":"11","author":"E Dumonteil","year":"2012","journal-title":"Expert review of vaccines"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/21645515.2016.1242540","article-title":"Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease","volume":"13","author":"CA Seid","year":"2017","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00876-17","article-title":"Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease","volume":"86","author":"K Jones","year":"2018","journal-title":"Infection and immunity"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"e1004594","DOI":"10.1371\/journal.ppat.1004594","article-title":"A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy","volume":"11","author":"IR Pereira","year":"2015","journal-title":"PLoS pathogens"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","article-title":"Pathogenesis of chronic Chagas heart disease","volume":"115","author":"JA Marin-Neto","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0167-5273(91)90012-E","article-title":"The pattern of myocardial fibrosis in chronic Chagas\u2019 heart disease","volume":"30","author":"MA Rossi","year":"1991","journal-title":"International journal of cardiology"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"EB Lindblad","year":"2004","journal-title":"Immunology and cell biology"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1473-3099(11)70099-8","article-title":"Targeting of Toll-like receptors: a decade of progress in combating infectious diseases","volume":"11","author":"M Hedayat","year":"2011","journal-title":"The Lancet infectious diseases"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s11095-009-9859-5","article-title":"MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020)","volume":"26","author":"BC Baudner","year":"2009","journal-title":"Pharm Res"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"e87082","DOI":"10.1371\/journal.pone.0087082","article-title":"Plasma cytokine expression is associated with cardiac morbidity in chagas disease","volume":"9","author":"GR Sousa","year":"2014","journal-title":"PloS one"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.4049\/jimmunol.173.9.5688","article-title":"Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi","volume":"173","author":"AC Oliveira","year":"2004","journal-title":"Journal of immunology"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4049\/jimmunol.156.2.628","article-title":"Down-regulation of T lymphocyte activation in vitro and in vivo induced by glycoinositolphospholipids from Trypanosoma cruzi. Assignment of the T cell-suppressive determinant to the ceramide domain","volume":"156","author":"NA Gomes","year":"1996","journal-title":"Journal of immunology"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1128\/IAI.70.7.3736-3743.2002","article-title":"Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses","volume":"70","author":"C Brodskyn","year":"2002","journal-title":"Infection and immunity"},{"issue":"9\u201310","key":"ref44","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0264-410X(02)00737-5","article-title":"Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice","volume":"21","author":"M Przetak","year":"2003","journal-title":"Vaccine"},{"key":"ref45","first-page":"277","article-title":"Vaccine Design: The Subunit and Adjuvant Approach","author":"G Ott","year":"1995"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/jpet.300.2.655","article-title":"A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity","volume":"300","author":"LD Hawkins","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0008-6363(03)00361-4","article-title":"Pathophysiology of the heart in Chagas\u2019 disease: current status and new developments","volume":"60","author":"L Higuchi Mde","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijcard.2006.03.004","article-title":"Clinical aspects of the Chagas\u2019 heart disease","volume":"115","author":"G Punukollu","year":"2007","journal-title":"International journal of cardiology"},{"key":"ref49","first-page":"75","article-title":"Assessment of speckle tracking strain predictive value for myocardial fibrosis in subjects with Chagas disease","volume":"8","author":"CT Macedo","year":"2015","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"4","key":"ref50","article-title":"Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease","volume":"86","author":"K Jones","year":"2018","journal-title":"Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/0074-0276140033","article-title":"Severity of chronic experimental Chagas\u2019 heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease","volume":"109","author":"IR Pereira","year":"2014","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"9","key":"ref52","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00127-17","article-title":"Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy","volume":"85","author":"V Konduri","year":"2017","journal-title":"Infection and immunity"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.xphs.2017.12.014","article-title":"Characterization and Stability of Trypanosoma cruzi 24-C4 (Tc24-C4), a Candidate Antigen for a Therapeutic Vaccine Against Chagas Disease","volume":"107","author":"AB Biter","year":"2018","journal-title":"Journal of pharmaceutical sciences"},{"key":"ref54","article-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1590\/S0074-02762005000300012","article-title":"Trypanosoma cruzi isolates from Mexican and Guatemalan acute and chronic chagasic cardiopathy patients belong to Trypanosoma cruzi I","volume":"100","author":"R Ruiz-Sanchez","year":"2005","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13071-015-0770-0","article-title":"Usefulness of real time PCR to quantify parasite load in serum samples from chronic Chagas disease patients","volume":"8","author":"MF Melo","year":"2015","journal-title":"Parasit Vectors"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.actatropica.2007.05.019","article-title":"Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples","volume":"103","author":"M Piron","year":"2007","journal-title":"Acta tropica"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneumeth.2009.04.016","article-title":"The optimization of TaqMan real-time RT-PCR assay for transcriptional profiling of GABA-A receptor subunit plasticity","volume":"181","author":"O Gangisetty","year":"2009","journal-title":"J Neurosci Methods"},{"issue":"3","key":"ref59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.actatropica.2012.05.002","article-title":"Real-time PCR strategy for parasite quantification in blood and tissue samples of experimental Trypanosoma cruzi infection","volume":"123","author":"S Caldas","year":"2012","journal-title":"Acta Trop"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"e1216","DOI":"10.1371\/journal.pntd.0001216","article-title":"Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome","volume":"5","author":"S Cencig","year":"2011","journal-title":"PLoS neglected tropical diseases"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0007413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T02:06:39Z","timestamp":1694916399000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007413"}},"subtitle":[],"editor":[{"given":"Helton da Costa","family":"Santiago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,30]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007413","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,30]]}}}